Headline: Universal bags GSK account for two new drugs
GlaxoSmithKline has appointed Universal McCann to coordinate planning and buying for the launch of two drugs in North Asia. Combined billings for both campaigns is expected to be around US$4.5 million. Creative will be handled by McCann Healthcare.